Medicamen Lifesciences Begins Operations, Expands Pharmaceutical Manufacturing

Medicamen Lifesciences Begins Operations, Expands Pharmaceutical Manufacturing

• Year: 2022
• October 23, 2002

Medicamen Lifesciences, a subsidiary of MEDICAMEN BIOTECH, officially launched operations in 2022. The company specializes in the manufacturing and marketing of pharmaceutical products, with a focus on Anti-hypertensives, Antidiabetics, and Cardiology treatments. Currently, Medicamen Lifesciences operates eight state-of-the-art manufacturing facilities that comply with WHO, EU-GMP, and USFDA standards. As part of its growth strategy, the company plans to further expand its operations nationwide, aiming to strengthen its presence in the pharmaceutical sector.